To the Editor We read with great interest the analysis of US National Transplant Registry data by Choi et al. 1 This sophisticated analysis showed higher facility-level organ offer acceptance rates were associated with lower waitlist mortality, which is not surprising since the logical result of a high acceptance rate is fewer people waiting on the waitlist. Additionally, posttransplant mortality was equivalent among firstrank vs lower-rank offers, indicating, they concluded, that outcomes would be the same regardless of who accepted the organ. The findings are timely considering current revisions in United Network for Organ Sharing allocation and provide an avenue for further efforts to reduce waitlist mortality and improve overall transplant outcomes.Nonetheless, there are issues that ought to be further explored as we interpret these findings. First, higher surgical volumes generally result in better outcomes. 2 Importantly, hospital structural factors may influence this observed association more than simply individual surgeon volume. Logically, transplant programs with high organ acceptance rates would have more organs to transplant and therefore higher volumes compared with programs with similar number of offers but a lower acceptance rate. How does the volume-outcomes relationship contribute to the findings by Choi et al 1 ; are lower acceptance rates perhaps a consequence of those same structural factors that foster the volume-outcome relationship (fewer available surgeons; limited availability of resources, such as dedicated beds and procuring teams; or risk-averse multidisciplinary teams)?Second, since this retrospective analysis shows association but not necessarily causation, it is possible that centers with higher recent transplant mortality rates have become more selective to improve their publicly reported transplant outcomes. They may reject organs looking for the perfect donor to theoretically increase the odds of a better outcome in the immediate future.Third, did the authors consider immortal time bias, accounting for time alive on the waitlist? Without a timedependent analysis to account for this bias, Choi et al 1 may have falsely overestimated the survival penalty of the varying acceptance rates. For instance, centers with lower offers could have sicker patients who ultimately do not undergo a transplant. Finally, considering new allocation systems as organs are offered from distant centers with higher travel time and changing recipient characteristics, a follow-up study to evaluate organ offer and acceptance would be timely.Again, a well-done, important study that may result in policy and structural changes for organ offer evaluation, reimbursement for transplant centers, or potentially universal guidelines for organ acceptability in the current era of public scrutiny.